Loading...
Safety, tolerability and appropriate use of nintedanib in idiopathic pulmonary fibrosis
BACKGROUND: Idiopathic pulmonary fibrosis (IPF) is a progressive disease characterised by dyspnea and loss of lung function. METHODS: Using pooled data from the replicate, randomized, 52-week, placebo-controlled INPULSIS(®) trials, we characterized the safety and tolerability of nintedanib 150 mg tw...
Saved in:
| Published in: | Respir Res |
|---|---|
| Main Authors: | , , , , , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
BioMed Central
2015
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4581488/ https://ncbi.nlm.nih.gov/pubmed/26400368 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12931-015-0276-5 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|